On the recordNovember 16, 2015
If we reduce that data exclusivity time, especially with regard to bio, you're talking about having to charge a lot more...
Source
congress.govIf we reduce that data exclusivity time, especially with regard to bio, you're talking about having to charge a lot more...
Senator Hatch warns that reducing data exclusivity could lead to higher drug prices.
Share
More from Orrin Hatch
Those backlogs at the Social Security Administration are unacceptable to many, if not most, of us here in the Senate.
It is disappointing the ranking member feels a need to question a statement that I made during the hearing.